{"contentid": 488411, "importid": NaN, "name": "Sputnik V production launched in Argentina", "introduction": "The Russian Direct Investment Fund (RDIF), Russia\u00e2\u0080\u0099s sovereign wealth fund, and Laboratorios Richmond SACIF today announced the production of the first batch of the Russian Sputnik V vaccine against Covid-19 in Argentina.", "content": "<p>The Russian Direct Investment Fund (RDIF), Russia&rsquo;s sovereign wealth fund, and Laboratorios Richmond SACIF today announced the production of the first batch of the Russian Sputnik V vaccine against Covid-19 in Argentina.&nbsp;</p>\n<p>Argentina has become the first country in Latin America to start the production of Sputnik V. The RDIF and partners facilitated the technology transfer to local drugmaker Laboratorios Richmond. The first batch will be shipped to the Gamaleya Center, which develop the vaccine, for the quality control. Full-scale production of the vaccine is due to start in June.&nbsp;</p>\n<p>Argentina was the first country in Latin America to officially register Sputnik V. The vaccine was registered in the country under the emergency use authorization procedure and vaccination against coronavirus with the Russian vaccine started on December, 29 2020. Sputnik V produced in Argentina could be exported to countries of Central and Latin America at a later stage.&nbsp;</p>\n<p>To date Sputnik V has been registered in 60 countries globally with total population of 3 billion people. Efficacy of Sputnik V is 97.6% based on the analysis of data on coronavirus infection rate among those in Russia vaccinated with both components of Sputnik V from December 5, 2020 to March 31, 2021.&nbsp;</p>\n<p>&ldquo;We are very excited about the possibility of producing Sputnik V in Argentina, a vaccine with which we are already protecting a large part of our population with excellent results. It will be a great opportunity to advance in the fight against the pandemic not only in Argentina, but also in Latin America,&rdquo; said Alberto Fern&aacute;ndez, President of Argentina.</p>\n<p>RDIF chief executive Kirill Dmitriev added: &ldquo;Argentina was the first country of Latin America to approve Sputnik V and begin using it to vaccinate the population. Today we are delighted to announce that Argentina has become the first country of the region to launch the production of Sputnik V thanks to partnership between RDIF and Laboratorios Richmond. Sputnik V is approved in more than 10 countries of Latin and Central America and production in Argentina will help facilitate deliveries to other partners in the region.&rdquo;</p>\n<p>&nbsp;</p>", "date": "2021-04-21 10:29:00", "meta_title": "Sputnik V production launched in Argentina", "meta_keywords": "Sputnik V, Production, Argentina, Lab Richmod, Gamaleya, RDIF", "meta_description": "Sputnik V production launched in Argentina", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-04-21 10:17:42", "updated": "2021-04-21 10:36:03", "access": NaN, "url": "https://www.thepharmaletter.com/article/sputnik-v-production-launched-in-argentina", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "vaccine_sputnik_big.jpg", "image2id": NaN, "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Pharmaceutical", "therapy area_tag": "Infectious diseases, Vaccines", "topic_tag": "Coronavirus, Focus On, Production", "geography_tag": "Argentina, Russia", "company_tag": "Gamaleya, Laboratorios Richmond, RDIF", "drug_tag": "Sputnik V", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-04-21 10:29:00"}